Difference between revisions of "Part:BBa K1216007"
(→Site directed mutagenesis of the BBa_R0062 pLuxR wild type promoter) |
(→Characterization of the pLuxR variant dose response to OHHL using plate reader analysis and FACS single cell analysis) |
||
Line 27: | Line 27: | ||
===Characterization of the pLuxR variant dose response to OHHL using plate reader analysis and FACS single cell analysis=== | ===Characterization of the pLuxR variant dose response to OHHL using plate reader analysis and FACS single cell analysis=== | ||
+ | |||
+ | [[File:platereader.jpg]] | ||
+ | [[File:facsdatag1.jpg]] | ||
+ | [[File:AgaLiG1.jpg]] |
Revision as of 18:32, 3 October 2013
Variant of the wild-type pLuxR promoter with lower sensitivity
BBa_K1216007 is a variant of the wild-type pLuxR promoter with a lowered sensitivity for LuxR-AHL.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Site directed mutagenesis of the BBa_R0062 pLuxR wild type promoter to obtain the pLuxR variant BBa_K2126007
Our goal was to achieve mutations in the luxbox of the pLuxR BBa_R0062 promoter to shift the dose response curve of the promoter depending on the OHHL (3-oxo-hexanoyl-l-homoserine-l-lactone) concentration.
We did site directed mutagenisis of specific sites of the luxbox according to the results of the literature ()
We mutated the promoter directly in the J09855 construct and added a GFP reporter to be able to screen for differences in the dose response curves. In the end we isolate one mutated promoter which shows a 300'000 fold shift in sensivity. For more details see : Characterization of the pLuxR variant dose response to OHHL using plate reader analysis and FACS single cell analysis